China Prohibits Illumina’s Gene Sequencer Imports Amid Trade Tensions
China has restricted imports of genetic sequencers from Illumina following new U.S. tariffs. This ban is part of China’s response to trade tensions and follows Illumina’s designation on an “unreliable entity” list. The actions were attributed to Illumina’s non-compliance with normal market transaction principles.
The Chinese government has announced a ban on imports of genetic sequencers from Illumina, a U.S.-based medical equipment manufacturer. This decision was made shortly after the implementation of an additional 10% tariff on Chinese goods by the United States. The ban forms part of China’s broader response to these U.S. tariffs and follows Illumina’s placement on the “unreliable entity” list earlier this year.
China’s Ministry of Commerce reported that Illumina’s actions were deemed to have violated market transaction norms and discriminatory practices against Chinese companies. Consequently, the ministry stated that these actions significantly harmed the interests of Chinese enterprises. The ministry’s statement indicated that the regulations associated with the Unreliability List warranted such a ban on exporting gene sequencers to China.
Gene sequencing is a critical technology used to identify DNA and RNA sequences, which aids in the study of genetic variations related to various diseases and the diagnosis of rare genetic conditions. It was noted that China represents approximately 7% of Illumina’s total sales. Illumina has yet to provide a statement regarding the ban.
In summary, China has implemented a ban on Illumina’s gene sequencers in reaction to new U.S. tariffs and the company’s previous actions towards Chinese enterprises. This measure reflects escalating tensions in trade relations between the U.S. and China, particularly affecting technological importation and market accessibility. The implications of this ban may have significant ramifications for both Chinese enterprises and Illumina’s business operations in the region.
Original Source: www.usnews.com
Post Comment